Galectins role as predictive markers for anti-PD-1-based immunotherapy in non-small cell lung cancer.

被引：1
|
作者：
Capalbo, Carlo
Filetti, Marco
Scafetta, Giorgia
Marchetti, Paolo
Bartolazzi, Armando
机构：
[1] St Andrea Univ Hosp, Dept Med Oncol, Rome, Italy
[2] St Andrea Univ Hosp, Dept Oncol Pathol, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
    Goldfarb, Lucas
    Duchemann, Boris
    Chouahnia, Kader
    Zelek, Laurent
    Soussan, Michael
    EJNMMI RESEARCH, 2019, 9 (1)
  • [2] Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
    Lucas Goldfarb
    Boris Duchemann
    Kader Chouahnia
    Laurent Zelek
    Michael Soussan
    EJNMMI Research, 9
  • [3] T Cell Invigoration is Associated with the Clinical Response to Anti-PD-1-Based Immunotherapy in Non-Small Cell Lung Cancer
    Wu, Hui
    Weng, Gui Zhen
    Sun, Li Na
    Pan, Zhang Chi
    Zhang, Lu
    Chen, Qiang
    Shi, Chun Mei
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1141 - 1153
  • [4] A comparison of three clinical factors as predictive markers for response to immunotherapy in non-small cell lung cancer.
    Preeshagul, Isabel Ruth
    Sullivan, Kevin M.
    Paul, Doru
    Maki, Robert G.
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] DNA methylation profiles associated with response to anti-PD-1 immunotherapy in non-small cell lung cancer.
    Cho, Jae-Won
    Hong, Min Hee
    Ha, Sang-Jun
    Kim, Young-Joon
    Lee, Insuk
    Kim, Hye Ryun
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 33 - 33
  • [6] Immunologic monitoring markers of clinical responses to anti-PD-1 therapy for non-small cell lung cancer.
    Oka, Mikio
    Kurose, Koji
    Ohue, Yoshihiro
    Karasaki, Takahiro
    Futami, Junichiro
    Masuda, Takeshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Shimizu, Katsuhiko
    Nakata, Masao
    Hattori, Noboru
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Oga, Toru
    Kakimi, Kazuhiro
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 104 - 105
  • [7] Predictive immunological markers of anti-PD-1/PD-L1 therapy efficacy in non-small cell lung cancer
    Musaelyan, A. A.
    Lapin, S. V.
    Urtenova, M. A.
    Chistyakov, I. V.
    Nazarov, V. D.
    Akopov, A. L.
    Orlov, S. V.
    ANNALS OF ONCOLOGY, 2021, 32 : S1382 - S1382
  • [8] Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced non-small cell lung cancer.
    Xiao, HaiPing
    Chen, Kai
    Zheng, Yating
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment
    Su, Shu
    Chen, Fungjun
    Lv, Xin
    Qi, Liang
    Ding, Zhou
    Ren, Wei
    Wei, Ming
    Liu, Ye
    Yu, Lixia
    Liu, Baorui
    Wang, Lifeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (01)
  • [10] Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment
    Shu Su
    Fungjun Chen
    Xin Lv
    Liang Qi
    Zhou Ding
    Wei Ren
    Ming Wei
    Ye Liu
    Lixia Yu
    Baorui Liu
    Lifeng Wang
    Cancer Immunology, Immunotherapy, 2024, 73
12345